Leo Gordon, MD, provides an overview of current treatment strategies currently driven by NCCN guidelines. Leo Gordon, MD: The NCCN [National Comprehensive Cancer Network] is composed of faculty ...

Lung cancer is classified into two major categories: non-small cell lung cancer (NSCLC), which accounts for 85% of lung cancer cases, and small-cell lung cancer (SCLC), which accounts for the ...

Tissue structures are determined by both cell-cell adhesion and cell-matrix adhesion, with the latter describing interactions between cells and the extracellular matrix (ECM). The ECM is the ...

Measures of cell viability and cytotoxicity are essential for the development of new drug treatments for cancer. For a number of years, cell-based assays have been used to assess the impact of drugs ...

The ability to reprogram somatic cells to generate induced pluripotent stem (iPS) cells has generated tremendous interest and discussion since iPS cells were first produced from mouse cells in 2006 ...

Like all forms of cancer, lung cancer is defined by uncontrolled cell division caused by loss of physiological tissue homeostasis and failure of apoptotic cell death mechanisms. Aberrant cell ...

Programmed cell death (PCD) is not restricted to multicellular organisms. Different forms of death have been described in bacteria. Bacteria are able to induce cell death in a part of the population ...

The purpose of this article is to provide readers with a deeper understanding of the state-of-the-art technology and development surrounding in situ graphene liquid cells-TEM. Image Credit: Tatiana ...

The approval of tisagenlecleucel and axicabtagene ciloleucel in 2017 marked a milestone in the development of oncology therapies. Since 2017, the breakthrough in treatment or even cure of previously ...